Evidence mapPaperPMID 36811474Full record

Trial reportThe American journal of clinical nutrition2023

Enhanced secretion of satiety-promoting gut hormones in healthy humans after consumption of white bread enriched with cellular chickpea flour: A randomized crossover study.

Balazs H Bajka, Ana M Pinto, Natalia Perez-Moral, Shikha Saha, Peter Ryden, Jennifer Ahn-Jarvis, Alice van der Schoot, Catherine Bland, Sarah E Berry, Peter R Ellis and 1 more

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03994276 nacompletednot on this map

The Postprandial Effects After Consumption of Chick-Pea Oral Doses on Glucose, Insulin, and Gut Hormone Responses. The PEA-POD Study

TypeinterventionalSponsorKing's College LondonRan2019 to 2020Enrolled29ConditionsPostprandial PeriodArmsChickpea powder
NCT06508424 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Investigating the Glycaemic and Satiating Capacity of PulseOn® Enriched Foods: a Randomised Control Trial

TypeinterventionalSponsorSheffield Hallam UniversityRan2024 to 2024Enrolled50ConditionsGlycaemic Response, Appetitive Behavior, Energy IntakeArmsPulseOn, Wheat flour control
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. The Ketogenic Diet in Obesity Management: Friend or Foe?Cell biochemistry and biophysics · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Myths and misconceptions about childhood constipation.European journal of pediatrics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Balazs H BajkaBiopolymers Group, Departments of Biochemistry and Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom. Electronic address: Balazs.Bajka@kcl.ac.uk.
Ana M PintoBiopolymers Group, Departments of Biochemistry and Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Natalia Perez-MoralFood Innovation and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.
Shikha SahaFood Innovation and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.
Peter RydenFood Innovation and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.
Jennifer Ahn-JarvisFood Innovation and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.
Alice van der SchootBiopolymers Group, Departments of Biochemistry and Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Catherine BlandBiopolymers Group, Departments of Biochemistry and Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Sarah E BerryDiet and Cardiometabolic Group, Department of Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Peter R EllisBiopolymers Group, Departments of Biochemistry and Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Cathrina H EdwardsFood Innovation and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom. Electronic address: Cathrina.edwards@quadram.ac.uk.
King's College London · GBNorwich Research Park · GB

Funding

Biotechnology and Biological Sciences Research Council BB/PO23770/1Biotechnology and Biological Sciences Research Council BB/R012512/1Biotechnology and Biological Sciences Research Council BBS/E/F/00044427Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10343
6 · The paper itself

Abstract

backgroundDietary intake of pulses is associated with beneficial effects on body weight management and cardiometabolic health, but some of these effects are now known to depend on integrity of plant cells, which are usually disrupted by flour milling. Novel cellular flours preserve the intrinsic dietary fiber structure of whole pulses and provide a way to enrich preprocessed foods with encapsulated macronutrients.

objectivesThis study aimed to determine the effects of replacing wheat flour with cellular chickpea flour on postprandial gut hormones, glucose, insulin, and satiety responses to white bread.

methodsWe conducted a double-blind randomized crossover study in which postprandial blood samples and scores were collected from healthy human participants (n = 20) after they consumed bread enriched with 0%, 30%, or 60% (wt/wt) cellular chickpea powder (CCP, 50 g total starch per serving).

resultsBread type significantly affected postprandial glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) responses (time × treatment, P = 0.001 for both). The 60% CCP breads elicited significantly elevated and sustained release of these anorexigenic hormones [between 0% and 60% CPP-GLP-1: mean difference incremental area under the curve (iAUC), 3101 pM/min; 95% CI: 1891, 4310; P-adjusted < 0.001; PYY: mean difference iAUC, 3576 pM/min; 95% CI: 1024, 6128; P-adjusted = 0.006] and tended to increase fullness (time × treatment, P = 0.053). Moreover, bread type significantly influenced glycemia and insulinemia (time × treatment, P < 0.001, P = 0.006, and P = 0.001 for glucose, insulin, and C-peptide, respectively), with 30% CCP breads eliciting a >40% lower glucose iAUC (P-adjusted < 0.001) than the 0% CCP bread. Our in vitro studies revealed slow digestion of intact chickpea cells and provide a mechanistic explanation for the physiologic effects.

conclusionsThe novel use of intact chickpea cells to replace refined flours in a white bread stimulates an anorexigenic gut hormone response and has potential to improve dietary strategies for prevention and treatment of cardiometabolic diseases. This study was registered at clinicaltrials.gov as NCT03994276.

Indexed as

Cardiovascular DiseasesCicerGastrointestinal HormonesBlood GlucoseBreadCross-Over StudiesFlourGlucagon-Like Peptide 1GlucoseHumansInsulinPeptide YYPostprandial PeriodTriticumBlood GlucoseGastrointestinal HormonesGlucagon-Like Peptide 1GlucoseInsulinPeptide YYbioaccessibilitydietary fiberGLP-1intact plant cellslegumesPYYrandomized crossoversatiety

Identifiers

PMID36811474
PMCPMC10131617
OpenAlexW4312209777

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.